410 related articles for article (PubMed ID: 29085965)
1. PET and SPECT imaging of melanoma: the state of the art.
Wei W; Ehlerding EB; Lan X; Luo Q; Cai W
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):132-150. PubMed ID: 29085965
[TBL] [Abstract][Full Text] [Related]
2. Whole-Body [
Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled Liposomes for Nuclear Imaging Probes.
Low HY; Yang CT; Xia B; He T; Lam WWC; Ng DCE
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175207
[TBL] [Abstract][Full Text] [Related]
4. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
6. Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.
Kong FL; Ford RJ; Yang DJ
Biomed Res Int; 2013; 2013():626910. PubMed ID: 23841079
[TBL] [Abstract][Full Text] [Related]
7.
Chakravarty R; Chakraborty S; Dash A
Mol Pharm; 2016 Nov; 13(11):3601-3612. PubMed ID: 27709959
[TBL] [Abstract][Full Text] [Related]
8. MC1R and melanin-based molecular probes for theranostic of melanoma and beyond.
Shi H; Cheng Z
Acta Pharmacol Sin; 2022 Dec; 43(12):3034-3044. PubMed ID: 36008707
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.
Annunziata S; Laudicella R; Caobelli F; Pizzuto DA; Aimn Working Group Y
Curr Radiopharm; 2020; 13(1):6-13. PubMed ID: 31749438
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
[TBL] [Abstract][Full Text] [Related]
12. [Nuclear medicine imaging: new radiotracers and future techniques].
Semah F
Neurochirurgie; 2008 May; 54(3):231-5. PubMed ID: 18440564
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma.
Kumar R; Alavi A
Curr Opin Oncol; 2005 Mar; 17(2):154-9. PubMed ID: 15725921
[TBL] [Abstract][Full Text] [Related]
14. Theranostics: The Role of Quantitative Nuclear Medicine Imaging.
Könik A; O'Donoghue JA; Wahl RL; Graham MM; Van den Abbeele AD
Semin Radiat Oncol; 2021 Jan; 31(1):28-36. PubMed ID: 33246633
[TBL] [Abstract][Full Text] [Related]
15. Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.
Schüle SC; Eigentler TK; Garbe C; la Fougère C; Nikolaou K; Pfannenberg C
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):482-8. PubMed ID: 26384681
[TBL] [Abstract][Full Text] [Related]
16. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
Kong FL; Kim EE; Yang DJ
Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
[TBL] [Abstract][Full Text] [Related]
17. [Established nuclear medicine techniques for tumour diagnosis (tumour SPECT): can they still compete with (18)F-FDG-PET?].
Schmidt M; Eschner W; Dietlein M; Theissen P; Schicha H
Nuklearmedizin; 2005 Feb; 44(1):37-48; quiz N2-3. PubMed ID: 15711728
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled vitamins as the potential diagnostic probes for targeted tumor imaging.
Shahrokhi P; Farahani AM; Tamaddondar M
Bioorg Chem; 2022 May; 122():105717. PubMed ID: 35272219
[TBL] [Abstract][Full Text] [Related]
20. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
